The effect of timing of post-operative radiation on outcomes in anaplastic thyroid cancer. [PDF]
Bonner AB +4 more
europepmc +1 more source
GERD and Upper Aerodigestive Tract Cancer Risk: A Systematic Review and Meta‐Analysis
ABSTRACT Objective Gastroesophageal reflux disease (GERD) is highly prevalent, yet its association with upper aerodigestive tract (UADT) cancers beyond esophageal adenocarcinoma remains incompletely defined. This systematic review and meta‐analysis aimed to quantify the risk of specific UADT cancers in individuals with GERD.
Janice Huang +10 more
wiley +1 more source
Prognosis of differentiated thyroid cancer in patients with Graves' disease: a meta-analysis. [PDF]
Zhang D +5 more
europepmc +1 more source
Are There Best Ways to Respond to a Patient With an AI‐Generated Answer You May Disagree With?
With the increasing use of generative artificial intelligence by patients, discrepancies in discussion can arise during the patient–physician clinic visit. This paper seeks to address practical guidelines for responding during a clinical encounter in which the physician disagrees with an AI‐generated medical answer brought forth by a patient.
Priyanka K. Bisarya +2 more
wiley +1 more source
EpCAM silencing suppresses aggressive phenotypes and induces partial redifferentiation in anaplastic thyroid cancer cells. [PDF]
Nakamura T, Shibata T, Ito KI.
europepmc +1 more source
Outcomes of in vitro fertilization for women with thyroid cancer: a case report. [PDF]
Wang W, Yang J, Liao P, Li L, Guo Y.
europepmc +1 more source
Choice and Death: Analysis of Medical Assistance in Dying for Head and Neck Cancer in Ontario
The uptake of MAiD for head and neck cancer (HNC) has been steadily increasing since 2016, when MAiD first became available in Canada. Our study projects a substantial increase in the future use of MAiD for patients with HNC. As such, our health system needs to re‐evaluate and implement the necessary infrastructure to support the projected increase in ...
Tanika Curry +8 more
wiley +1 more source
Baicalein inhibits the progression of thyroid cancer by suppressing the TPL2/MEK2/ERK2 pathway. [PDF]
Wu N +6 more
europepmc +1 more source

